SALIX PHARMACEUTICALS LTD — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2cac0aa0-985f-4c2a-987b-ef09fb5b45f9/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2014 | $-490.1M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-001199 |
| FY 2013 | $252.3M | 2013-01-01 – 2013-12-31 | evidence 0001193125-15-073225 |
| FY 2012 | $172.1M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-085041 |
| FY 2011 | $115.9M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-085075 |
| FY 2010 | $-6.2M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-085075 |
| FY 2009 | $-40.1M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-085075 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SALIX PHARMACEUTICALS LTD — all facts · Revenue · Net Income